Table 1.

Demographic characteristics of infants and children enrolled in the study.

Median age, months (range)	Vaccine (n = 27)	Placebo (n = 13)	P-value
Dose 1 (n = 40)	13 (6–35)	16 (6–29)	0.34
Dose 2 (n = 39)	18 (12–40)	23 (13–34)	0.27
Male, no (%)	17 (63)	7 (54)	0.73
Race, no (%)
Asian	0 (0)	1 (8)	0.33
Black	9 (32)	3 (23)	0.72
Caucasian	14 (50)	9 (69)	0.33
Multi-racial/unknown	4 (14)	0 (0)	0.28
Hispanic, no (%)	9 (33%)	2 (15%)	0.29